This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fletcher, J. Articles by Townend, J. N. Search for Related Content PubMed PubMed Citation Articles by Fletcher, J. Articles by Townend, J. N.

Acute aldosterone antagonism improves cardiac vagal control in humans

Janine Fletcher, BSc (Hons) PhD^*, Ashesh N. Buch, MBChB, MRCP^,*, Helen C. Routledge, BSc, MBChB, MRCP, Saqib Chowdhary, MBBS PhD, MRCP, John H. Coote, PhD, DSc^* and Jonathan N. Townend, MBChB, MD, FRCP

^* Department of Physiology, University of Birmingham, Edgbaston, Birmingham, United Kingdom
Department of Cardiovascular Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom

View larger version (35K): [in a new window]   Figure 1 Power spectral density plots showing the distribution of power (ms2) against frequency (Hz). Representative spectral plots from a subject at baseline and following saline or potassium canrenoate infusion, demonstrating the increase in high-frequency power (0.2 Hz) after active treatment with no significant change in low-frequency power (0.1 Hz) compared to control.